Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB9408775Aexternal-prioritypatent/GB9408775D0/en
Application filed by IndividualfiledCriticalIndividual
Publication of CA2183764A1publicationCriticalpatent/CA2183764A1/en
Application grantedgrantedCritical
Publication of CA2183764CpublicationCriticalpatent/CA2183764C/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Medicinal Preparation
(AREA)
Abstract
The invention relates to the use of certain methanebisphosphonic acid derivatives (for the manufacture of a pharmaceutical composition) for the prevention and treatment of prosthesis loosening and prosthesis migration in mammals including man.
CA002183764A1994-05-041995-04-24Use of certain methanebisphosphonic acid derivatives to prevent prosthesis loosening and prosthesis migration
Expired - Fee RelatedCA2183764C
(en)
Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of atrophy of skin and/or mucous membranes
4-thiazolidinone, rhodanine and 1,3-oxathiolan-5-one derivatives for the preparation of pharmaceutical compositions suitable for the treatment of multiple sclerosis